SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001659617-18-000093
Filing Date
2018-08-10
Accepted
2018-08-10 16:23:25
Documents
53
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mbrx-20180630.htm   iXBRL 10-Q 1264972
2 EXHIBIT 31.1 a2018q2ex311nextgen.htm EX-31.1 12211
3 EXHIBIT 31.2 a2018q2ex312nextgen.htm EX-31.2 12098
4 EXHIBIT 32.1 a2018q2ex321nextgen.htm EX-32.1 7911
5 EXHIBIT 32.2 a2018q2ex322nextgen.htm EX-32.2 8302
11 mbrx-20180630_g1.jpg GRAPHIC 12313
  Complete submission text file 0001659617-18-000093.txt   5874507

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mbrx-20180630.xsd EX-101.SCH 45379
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mbrx-20180630_cal.xml EX-101.CAL 51667
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mbrx-20180630_def.xml EX-101.DEF 199877
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mbrx-20180630_lab.xml EX-101.LAB 493939
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mbrx-20180630_pre.xml EX-101.PRE 317494
12 EXTRACTED XBRL INSTANCE DOCUMENT mbrx-20180630_htm.xml XML 1083282
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 181009125
SIC: 2834 Pharmaceutical Preparations